Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis
Interleukin-1 (IL-1) plays an essential role in the immune pro-inflammatory process, which is regarded as one of many factors in the development of type 2 diabetes mellitus (T2DM). Several case-control studies have illustrated the association of the IL-1B (-511) (rs16944, Chr 2:112,837,290, C/T Intr...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2021-10-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/12384.pdf |
| _version_ | 1797421740752633856 |
|---|---|
| author | Juan Jiao Zhaoping Wang Yanfei Guo Jie Liu Xiuqing Huang Xiaolin Ni Danni Gao Liang Sun Xiaoquan Zhu Qi Zhou Ze Yang Huiping Yuan |
| author_facet | Juan Jiao Zhaoping Wang Yanfei Guo Jie Liu Xiuqing Huang Xiaolin Ni Danni Gao Liang Sun Xiaoquan Zhu Qi Zhou Ze Yang Huiping Yuan |
| author_sort | Juan Jiao |
| collection | DOAJ |
| description | Interleukin-1 (IL-1) plays an essential role in the immune pro-inflammatory process, which is regarded as one of many factors in the development of type 2 diabetes mellitus (T2DM). Several case-control studies have illustrated the association of the IL-1B (-511) (rs16944, Chr 2:112,837,290, C/T Intragenic, Transition Substitution) and IL-1RN (VNTR) (gene for IL-1 receptor antagonist, IL-1RA, 86 bp tandem repeats in intron 2) polymorphisms with T2DM risk. However, the results were inconsistent and inconclusive. We performed a meta-analysis (registry number: CRD42021268494) to assess the association of the IL-1B (-511) and IL-1RN (VNTR) polymorphisms with T2DM risk. Random-effects models were applied to calculate the pooled ORs (odds ratios) and 95% CIs (confidence intervals) to test the strength of the association in the overall group and subgroups stratified by ethnicity, respectively. Between-study heterogeneity and publication bias were evaluated by the Q-test, I2 statistic, Harbord test, and Peters test accordingly. Sensitivity analyses were also performed. A total of 12 publications evaluating the association of IL-1B (-511) and IL-1RN (VNTR) polymorphisms with the risk of T2DM development were included. The meta-analysis showed that IL-1RN (VNTR) was related to the increasing development of T2DM risk in the recessive model (OR = 1.62, 95% CI [1.09–2.42], Phet = 0.377, Pz = 0.018) and in the homozygous model (OR = 2.02, 95% CI [1.07–3.83], Phet = 0.085, Pz = 0.031), and the IL-1RN 2* allele was found a significant association with evaluated T2DM risk in all ethnicities (OR = 2.08, 95% CI [1.43–3.02], Phet < 0.001, Pz < 0.001) and in EA (OR = 2.01, 95% CI [1.53–2.66], Phet = 0.541, Pz < 0.001). Moreover, stratification by ethnicity revealed that IL-1B (-511) was associated with a decreased risk of T2DM in the dominant model (OR=0.76, 95% CI [0.59–0.97], Phet = 0.218, Pz = 0.027) and codominant model (OR = 0.73, 95% CI [0.54–0.99], Phet = 0.141, Pz = 0.040) in the East Asian (EA) subgroup. Our results suggest that the IL-1RN 2* allele and 2*2* homozygous polymorphism are strongly associated with increasing T2DM risk and that the IL-1B (-511) T allele polymorphism is associated with decreasing T2DM risk in the EA subgroup. |
| first_indexed | 2024-03-09T07:21:48Z |
| format | Article |
| id | doaj.art-4898b1530a9e4d758ad7b885e394dd57 |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T07:21:48Z |
| publishDate | 2021-10-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-4898b1530a9e4d758ad7b885e394dd572023-12-03T07:14:57ZengPeerJ Inc.PeerJ2167-83592021-10-019e1238410.7717/peerj.12384Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysisJuan Jiao0Zhaoping Wang1Yanfei Guo2Jie Liu3Xiuqing Huang4Xiaolin Ni5Danni Gao6Liang Sun7Xiaoquan Zhu8Qi Zhou9Ze Yang10Huiping Yuan11The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaDepartment of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. ChinaDepartment of Clinical Laboratory, the Seventh Medical Center, Chinese PLA General Hospital, Beijing, ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaThe Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. ChinaInterleukin-1 (IL-1) plays an essential role in the immune pro-inflammatory process, which is regarded as one of many factors in the development of type 2 diabetes mellitus (T2DM). Several case-control studies have illustrated the association of the IL-1B (-511) (rs16944, Chr 2:112,837,290, C/T Intragenic, Transition Substitution) and IL-1RN (VNTR) (gene for IL-1 receptor antagonist, IL-1RA, 86 bp tandem repeats in intron 2) polymorphisms with T2DM risk. However, the results were inconsistent and inconclusive. We performed a meta-analysis (registry number: CRD42021268494) to assess the association of the IL-1B (-511) and IL-1RN (VNTR) polymorphisms with T2DM risk. Random-effects models were applied to calculate the pooled ORs (odds ratios) and 95% CIs (confidence intervals) to test the strength of the association in the overall group and subgroups stratified by ethnicity, respectively. Between-study heterogeneity and publication bias were evaluated by the Q-test, I2 statistic, Harbord test, and Peters test accordingly. Sensitivity analyses were also performed. A total of 12 publications evaluating the association of IL-1B (-511) and IL-1RN (VNTR) polymorphisms with the risk of T2DM development were included. The meta-analysis showed that IL-1RN (VNTR) was related to the increasing development of T2DM risk in the recessive model (OR = 1.62, 95% CI [1.09–2.42], Phet = 0.377, Pz = 0.018) and in the homozygous model (OR = 2.02, 95% CI [1.07–3.83], Phet = 0.085, Pz = 0.031), and the IL-1RN 2* allele was found a significant association with evaluated T2DM risk in all ethnicities (OR = 2.08, 95% CI [1.43–3.02], Phet < 0.001, Pz < 0.001) and in EA (OR = 2.01, 95% CI [1.53–2.66], Phet = 0.541, Pz < 0.001). Moreover, stratification by ethnicity revealed that IL-1B (-511) was associated with a decreased risk of T2DM in the dominant model (OR=0.76, 95% CI [0.59–0.97], Phet = 0.218, Pz = 0.027) and codominant model (OR = 0.73, 95% CI [0.54–0.99], Phet = 0.141, Pz = 0.040) in the East Asian (EA) subgroup. Our results suggest that the IL-1RN 2* allele and 2*2* homozygous polymorphism are strongly associated with increasing T2DM risk and that the IL-1B (-511) T allele polymorphism is associated with decreasing T2DM risk in the EA subgroup.https://peerj.com/articles/12384.pdfIL-1B (-511)IL-1RN (VNTR)PolymorphismType 2 diabetes mellitusMeta-analysis |
| spellingShingle | Juan Jiao Zhaoping Wang Yanfei Guo Jie Liu Xiuqing Huang Xiaolin Ni Danni Gao Liang Sun Xiaoquan Zhu Qi Zhou Ze Yang Huiping Yuan Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis PeerJ IL-1B (-511) IL-1RN (VNTR) Polymorphism Type 2 diabetes mellitus Meta-analysis |
| title | Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis |
| title_full | Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis |
| title_fullStr | Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis |
| title_full_unstemmed | Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis |
| title_short | Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis |
| title_sort | association between il 1b 511 il 1rn vntr polymorphisms and type 2 diabetes a systematic review and meta analysis |
| topic | IL-1B (-511) IL-1RN (VNTR) Polymorphism Type 2 diabetes mellitus Meta-analysis |
| url | https://peerj.com/articles/12384.pdf |
| work_keys_str_mv | AT juanjiao associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT zhaopingwang associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT yanfeiguo associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT jieliu associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT xiuqinghuang associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT xiaolinni associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT dannigao associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT liangsun associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT xiaoquanzhu associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT qizhou associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT zeyang associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis AT huipingyuan associationbetweenil1b511il1rnvntrpolymorphismsandtype2diabetesasystematicreviewandmetaanalysis |